PHARMACOLOGICAL STUDIES OF STAY-ON POWER CAPSULES IN RABBITS
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 2
Abstract
The main objective of this study was to perform pharmacological evaluation of Stay-On Power Capsules in Rabbits (Non-Rodents) namely the aphrodisiac activity. The present investigation deals with Pharmacological Studies (Mating behaviour study, mating performance test, Hormonal analysis, Reproductive organ and spermal analysis) of Stay-On Power Capsules in Non-Rodents administered orally by gavage to Rabbits in accordance with the schedule Y of drugs and Cosmetic Act (2005). The acute toxicity study of Stay-On Power Capsules was done by up and down method. After the completion of acute toxicity studies, three different doses were selected for aphrodisiac activity such as 150, 300, and 600 mg/kg. Volume of oral administration was 1 ml/100 g of animals. Animals were randomly divided into five groups with six animals per group. Group I represented the control animals treated with normal water only; Groups II, III, and IV were treated with oral suspension of Stay-On Power Capsules at 18:00 h, at doses of 150, 300, and 600 mg/kg, respectively; and Group V served as a positive control treated with Sildenafil citrate of 5 mg/kg body weight. All the treatments were continued for 3 weeks only. A mating behaviour study revealed that continuous administration for 3 weeks, all the doses of Stay-On Power Capsules were able to significantly decrease mount and intromission latencies, and decrease ejaculatory latency and post ejaculatory interval when compared to vehicle control and standard drug treated Rabbits. It also resulted in a dose dependent increase in the mating performance and showed increasing ratio of testes body weight along with increase in sperm count as compared to the control group. Key Words: Stay-On Power Capsules, Pharmacological Studies, aphrodisiac activity, mating behaviour, mating performance
Authors and Affiliations
Mrinmoy Gautam, Saiprasanna Behera
Keywords
Related Articles
- EP ID EP294656
- DOI 10.22270/jddt.v7i2.1382
- Views 84
- Downloads 0
CRYSTAL ENGINEERING OF ANTIVIRAL AGENT EFAVIRENZ FOR SOLUBILITY ENHANCEMENT
In the current study, we attempted to improve the physicochemical properties of antiviral drug efavirenz through the cocrystal synthesis. The neat grinding performed to study the effect of coformer-fumaric acid (FA) on s...
FORMULATION AND EVALUATION OF BILAYER TABLETS OF BACLOFEN USING SYNTHETIC POLYMERS
Aim of study was to develop bilayer drug delivery for treatment of spasticity by delivering loading and maintenance dose for fast achievement of peak plasma concentration and maintaining the same respectively. The prepar...
FLAXSEEDS AND AJWAIN FOR PRIMARY HYPERLIPIDEMIA
Research work was single blind placebo-controlled, conducted at General Hospital, Lahore, Pakistan conducted from NOVEMBER 2015 to JANUARY 2016. 75 diagnosed primary hyperlipidemic patients were selected with age range...
Wound healing promoting activity of Earthworm, Eutyphoeus gammiei (Beddard): in vitro studies on human skin keratinocyte cell line (HaCat).
Earthworm, Eutyphoeus gammiei, homogenate (EGH) was screened for wound healing activity on human keratinocyte cell line, HaCat, by cell proliferation and migration assays. The maximum proliferation and migration of kerat...
ADEQUACY OF THE CURRENT RECOMMENDED DOSAGE OF CIPROFLOXACIN IN PRETERM AND TERM NEONATES WITH SEPSIS
Objectives: To determine the percentage of neonates with sepsis, on treatment with standard recommended dose of intravenous ciprofloxacin, who had the serum ciprofloxacin Peak concentration: Minimum inhibitory concentra...